NAMSA Acquires Syntactx, Joining Together to Form the Industry’s Leading Medical Device CRO

Learn More

Syntactx is the one clinical research organization clients can count on to move their clinical evidence from investigation to broad market adoption. Led by key thought leaders who understand first-hand what’s at stake, we pride ourselves on our high professional standards and are committed to delivering the best possible outcomes.

Our Story

Meet our dedicated team of experts

We have a world class team of clinical, analytical, and regulatory experts who partner with every client and bring their diverse experiences to every project.

Our breadth of knowledge guarantees our clients have a partner who will deliver the best results possible.


Meet Our Experts


NAMSA® Acquires Syntactx to Enhance End-to-End CRO Development Solutions.

Capabilities from investigation to evidence generation and market adoption

We partner with a wide range of clients from early-stage startups to multi-billion dollar corporations. We strive to deliver the solutions our clients need to create transformative therapies for patients worldwide.